Sponsor content
44 result(s) found, displaying 31 to 40
-
Prescription medicine decision summarySpikevax Bivalent Original/Omicron (elasomeran and imelasomeran) was approved for the prevention of COVID-19.
-
Australian public assessment report (AusPar)SPIKEVAX BIVALENT ORIGINAL/OMICRON - (elasomeran and imelasomer) for prevention of COVID-19
-
Prescription medicine registrationActive ingredients: elasomeran, imelasomeran.
-
Australian public assessment report (AusPar)Spikevax (elasomeran) for the prevention of COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older
-
Prescription medicine registrationActive ingredients: elasomeran.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Elasomeran
-
Prescription medicine registrationActive ingredients: elasomeran.
-
Prescription medicine registrationActive ingredients: elasomeran.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Elasomeran (mRNA-1273)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Elasomeran